|
Stories from the dialysis comunity across the globe.
|
|
Off topic: The world has just changed, but you don't know it yet. |
 |
 |
|
Nickel content in unused fuel also found to be in natural ratios: i.e. 58Ni (68.1%), 60Ni (26.2%), 61Ni (1.1%), 62Ni (3.6%), and 64Ni (0.9%), whereas the ash composition from SIMS is: 58Ni (0.8.%), 60Ni (0.5%), 61Ni (0%), 62Ni (98.7%), 64Ni (0%), and from ICP-MS: 58Ni (0.8%), 60Ni (0.3%), 61Ni (0%), 62Ni (99.3%), 64Ni (0%). So, the fuel is indeed changed at the nuclear level. Call it what you will, this is definitely LENR!
|
|
|
New study confirms benefits of a low carb diet, even when eating some saturated fat. |
|
|
|
NY Times: The new study was financed by the National Institutes of Health and published in the Annals of Internal Medicine. It included a racially diverse group of 150 men and women — a rarity in clinical nutrition studies — who were assigned to follow diets for one year that limited either the amount of carbs or fat that they could eat, but not overall calories.
|
|
PCSK9 inhibitor arilocumab lowers cholesterol and cardiovascular events |
|
|
|
European Society of Cardiology: At the European Society of Cardiology’s annual meeting in Barcelona, experts revealed that the drug alirocumab was effective in lowering the so-called bad cholesterol within weeks. The effect was even greater in a combination with statin treatment. The promising findings come from an interim safety analysis of one of the nine studies reported in July to have shown consistent LDL reductions. The analysis indicates that patients given alirocumab were less likely to suffer cardiovascular events, such as cardiac death, heart attack, stroke and chest pain requiring hospitalization.
|
|
|
Novel heart failure drug shows great promise. |
|
|
|
Reuters: LCZ696 is a two-in-one pill, taken twice a day, combining Diovan's active ingredient valsartan and another class of drug called a neprilysin inhibitor. In terms of side effects, patients on LCZ696 suffered more low blood pressure and non-serious swelling but less kidney impairment, high potassium and cough than the enalapril group.
|
|
Cyanotoxin factsheet from the EPA. |
|
|
|
EPA. This fact sheet provides public water suppliers basic information on human health effects, analytical screening tools, and the effectiveness of various treatment processes to remove or inactivate the three most important cyanotoxins that can occur in the waters of almost every part of the US and are listed on the third Candidate Contaminant List (CCL): microcystin-LR, anatoxin-a, and cylindrospermopsin.
|
|
|
|
|
<< Start < Prev 401 402 403 404 405 406 407 408 409 410 Next > End >>
|
|
Page 403 of 4210 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
